Sylwia Sudoł-Tałaj

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Polish Academy of Sciences(Current)

Maj Institute of Pharmacology

Jagiellonian University

Saarland University

Uniwersytet Komisji Edukacji Narodowej w Krakowie

Sylwia Sudoł-Tałaj is an author at Polish Academy of Sciences specializing in drug discovery, 5-hydroxytryptamine receptor pharmacology, and serotonergic pharmacology.

Publications per year

2022–2024

Publications

First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT<sub>6</sub> Agents with a Beneficial Neuroprotective Profile against Alzheimer’s Disease

Patryk Pyka, Wawrzyniec Haberek, Małgorzata Więcek et al. · Journal of Medicinal Chemistry · 2024 · 29 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Synthesis, computational and experimental pharmacological studies for (thio)ether-triazine 5-HT6R ligands with noticeable action on AChE/BChE and chalcogen-dependent intrinsic activity in search for new class of drugs against Alzheimer's disease

Kinga Czarnota-Łydka, Sylwia Sudoł-Tałaj, Katarzyna Kucwaj‐Brysz et al. · European Journal of Medicinal Chemistry · 2023 · 18 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

An exit beyond the pharmacophore model for 5-HT6R agents - a new strategy to gain dual 5-HT6/5-HT2A action for triazine derivatives with procognitive potential

Katarzyna Kucwaj‐Brysz, Wesam Ali, Rafał Kurczab et al. · Bioorganic Chemistry · 2022 · 11 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

1–3 of 3